Many companies were aware before the COVID-19 pandemic hit that a global pandemic arising from animal-human contact could happen—and that it was likely. Yet few companies were prepared with action plans when the real crisis unfolded. What lessons are we learning from this pandemic that can help us better prepare for the next public health crisis? What opportunities did businesses find to be resilient, and where did they face the greatest challenges? How might businesses, together with policymakers and civil society, learn from the current crisis to take preventive steps and avert or mitigate future disasters?
Additional speakers to be announced.
Global Vice President, Health and Wellbeing
Nebeyou Abebe serves as global vice president of health & wellbeing for Sodexo Group. He is responsible for enterprise-wide health and wellbeing strategy, advising clients on their workforce and community health and wellbeing goals, developing comprehensive employee health and wellbeing solutions, and establishing mutually beneficial partnerships with private, public, and non-profit entities. Prior to Sodexo, Abebe served as associate director of health systems at the Louisiana Public Health Institute (LPHI). At LPHI, Abebe helped transform the healthcare delivery system within Greater New Orleans. He also directed one of the largest population-based mobile health (mHealth) programs in the U.S. focused on diabetes risk awareness and prevention. Prior to LPHI, Abebe served as senior project director at the American Institutes for Research, where he directed national public health and education campaigns targeting vulnerable and high-risk populations.
Vice President, Global Health and Patient Access, Pfizer
President, The Pfizer Foundation
Caroline Roan oversees Pfizer’s Global Health and Patient Access (GH&PA) function, including the design of social investment strategies that drive access to quality healthcare, medicines, and vaccines for the most vulnerable populations; stakeholder engagement; and public reporting on environmental, social, and governance issues (ESG). During her tenure, Pfizer has refined its GH&PA strategy to better support the company’s evolving business priorities. The resulting GH&PA portfolio is a coordinated approach to strategic philanthropy and responsible investment which uses the full scope of the company’s resources to broaden access to medicines and strengthen health care delivery for underserved people. Prior to joining Pfizer, Roan worked on the Robert Wood Johnson Foundation’s Community Health Team, which focused on promoting individual and community health by increasing social support and connection. She was also associate director of the Center for Interdisciplinary Research on AIDS (CIRA) at Yale University’s Department of Epidemiology and Public Health.
Senior scientist and director of the Institute for Health and Productivity Studies (IHPS)
Johns Hopkins Bloomberg School of Public Health
Dr. Ron Z. Goetzel is senior scientist and director of the Institute for Health and Productivity Studies (IHPS) at the Johns Hopkins Bloomberg School of Public Health and Vice President of Consulting and Applied Research at IBM Watson Health. IHPS’ mission is to bridge the gap between academia, the business community, and the health care policy world.
At IBM Watson Health, Dr. Goetzel conducts research on the relationship between health and well-being, medical costs, and productivity. He has directed multiple evaluations of health promotion and disease prevention programs. Dr. Goetzel is president and CEO of The Health Project, which annually awards the C. Everett Koop Prize to employers demonstrating cost-effective health and well-being programs.
Cecile Oger works with BSR members to advance sustainability strategies and better partner with stakeholders to create more resilient and inclusive business practices. She also leads BSR’s global staffing process and people management in EMEA, which includes recruitment and professional development.
Oger leads projects on stakeholder engagement, materiality, and strategy, mostly in the healthcare; consumer products; and food, beverage, and agriculture sectors. She also leads the Healthcare Working Group.
Prior to joining BSR, Oger served as deputy director for SGS Sustainability Services. Her work involved developing service offerings for sustainable supply chains. Before that, she was executive director of SFSTP, one of the largest associations of industrial pharmacists in Europe. She started her career in the chemicals industry, working for Clariant in the U.K. and Canada.
Follow Cecile @CecileOger.
I felt this conference was life changing. I am truly inspired and am plotting both career and personal changes to live up to the great lessons I learned. Both the sessions and the networking were vital.